# FDA 483 - Roche Singapore Technical Operations Pte. Ltd. - August 01, 2022

Source: https://www.globalkeysolutions.net/records/483/roche-singapore-technical-operations-pte-ltd/a9662aa4-a6fe-402f-a06b-cad244103c24

> FDA 483 for Roche Singapore Technical Operations Pte. Ltd. on August 01, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Roche Singapore Technical Operations Pte. Ltd.
- Inspection Date: 2022-08-01
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Officers

- [Wendy Tan, PhD, Microbiologist](https://www.globalkeysolutions.net/people/wendy-tan-phd-microbiologist/24f63b1c-33e5-440c-9853-2a18c141afa3)
- [Michael A Moses, PhD, Biologist](https://www.globalkeysolutions.net/people/michael-a-moses-phd-biologist/baa0c916-00f7-4713-8aee-7c095d86d44c)
- [Katherine Jacobitz, IB Director](https://www.globalkeysolutions.net/people/katherine-jacobitz-ib-director/de115f4d-08de-4927-a17b-8b1a1e4de1c0)
- [Riley Myers, Ph.D.; Lead Biologist](https://www.globalkeysolutions.net/people/riley-myers-phd-lead-biologist/f9f7b2db-0820-4e31-95bf-27aa2b6568ea)

Company: https://www.globalkeysolutions.net/companies/roche-singapore-technical-operations-pte-ltd/e32730ce-85e1-4b01-8f9b-a8215d0593ca

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd